Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) closed at $13.43 in the last session, down -5.42% from day before closing price of $14.2. In other words, the price has decreased by -$5.42 from its previous closing price. On the day, 0.78 million shares were traded.
Ratios:
We take a closer look at CNTA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 14.37 and its Current Ratio is at 14.37. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on May 28, 2025, initiated with a Buy rating and assigned the stock a target price of $35.
On May 08, 2025, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $30.
On March 31, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $38.Piper Sandler initiated its Overweight rating on March 31, 2025, with a $38 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 25 ’25 when Weinhoff Gregory M sold 10,000 shares for $13.86 per share. The transaction valued at 138,642 led to the insider holds 122,279 shares of the business.
HUSSAIN IQBAL J sold 12,000 shares of CNTA for $168,218 on Jun 24 ’25. The General Counsel now owns 105,386 shares after completing the transaction at $14.02 per share. On Jun 24 ’25, another insider, Accardi Mario Alberto, who serves as the President, Orexin Program of the company, sold 15,000 shares for $14.00 each. As a result, the insider received 210,000 and left with 216,485 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 119.10 while its Price-to-Book (P/B) ratio in mrq is 4.64.
Stock Price History:
Over the past 52 weeks, CNTA has reached a high of $19.09, while it has fallen to a 52-week low of $8.46. The 50-Day Moving Average of the stock is 5.26%, while the 200-Day Moving Average is calculated to be -12.01%.
Shares Statistics:
A total of 133.55M shares are outstanding, with a floating share count of 84.74M. Insiders hold about 36.55% of the company’s shares, while institutions hold 57.60% stake in the company.
